Japan's Otsuka buys U.S. supplement maker Bonafide Health for $425m

Drugmaker aims to expand health food for women with its unit Pharmavite

20231201 Otsuka logo

Otsuka Pharmaceutical has been expanding its business of women's health food products and other fields through M&A. (Photo by Kohei Yamada)

Nikkei staff writers

TOKYO -- Japanese drugmaker Otsuka Pharmaceutical has acquired U.S. women's health food company Bonafide Health for $425 million, its parent Otsuka Holdings announced on Friday, in a move to diversify its portfolio of women's health food products.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.